Identifying cancer origin using circulating tumor cells

Circulating tumor cells (CTCs) have become an established clinical evaluation biomarker. CTC count provides a good correlation with the prognosis of cancer patients, but has only been used with known cancer patients, and has been unable to predict the origin of the CTCs. This study demonstrates the...

Descripción completa

Detalles Bibliográficos
Autores principales: Lu, Si-Hong, Tsai, Wen-Sy, Chang, Ying-Hsu, Chou, Teh-Ying, Pang, See-Tong, Lin, Po-Hung, Tsai, Chun-Ming, Chang, Ying-Chih
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4910938/
https://www.ncbi.nlm.nih.gov/pubmed/26828696
http://dx.doi.org/10.1080/15384047.2016.1141839

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4910938/
https://www.ncbi.nlm.nih.gov/pubmed/26828696
http://dx.doi.org/10.1080/15384047.2016.1141839

Ejemplares similares